Nakayama T - Search Results

1

A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.

Nakayama T, Aizawa C, Kuno-Sakai H. Nakayama T, et al. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):321-5. doi: 10.1016/s0091-6749(99)70508-7. J Allergy Clin Immunol. 1999. PMID: 9949325

2

A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies.

Makino S, Sasaki K, Nakayama T, Oka S, Urano T, Kimura M, Kawana R, Yamamura AM. Makino S, et al. Among authors: nakayama t. Am J Dis Child. 1990 Aug;144(8):905-10. doi: 10.1001/archpedi.1990.02150320069030. Am J Dis Child. 1990. PMID: 2198807 Clinical Trial.

3

Long-term regulation of interferon production by lymphocytes from children inoculated with live measles virus vaccine.

Nakayama T, Urano T, Osano M, Maehara N, Sasaki K, Makino S. Nakayama T, et al. J Infect Dis. 1988 Dec;158(6):1386-90. doi: 10.1093/infdis/158.6.1386. J Infect Dis. 1988. PMID: 3143767 No abstract available.

4

Cases of systemic immediate-type urticaria associated with acellular diphtheria-tetanus-pertussis vaccination.

Sakaguchi M, Nakayama T, Inouye S. Sakaguchi M, et al. Among authors: nakayama t. Vaccine. 1998 Jul;16(11-12):1138-40. doi: 10.1016/s0264-410x(98)80111-4. Vaccine. 1998. PMID: 9682371 Clinical Trial.

5

Minimum estimated incidence in Japan of anaphylaxis to live virus vaccines including gelatin.

Sakaguchi M, Nakayama T, Fujita H, Toda M, Inouye S. Sakaguchi M, et al. Among authors: nakayama t. Vaccine. 2000 Oct 15;19(4-5):431-6. doi: 10.1016/s0264-410x(00)00206-1. Vaccine. 2000. PMID: 11027805

6

Anaphylaxis to Japanese encephalitis vaccine.

Sakaguchi M, Nakashima K, Takahashi H, Nakayama T, Fujita H, Inouye S. Sakaguchi M, et al. Among authors: nakayama t. Allergy. 2001 Aug;56(8):804-5. doi: 10.1034/j.1398-9995.2001.056008804.x. Allergy. 2001. PMID: 11488694 No abstract available.

7

[Field trial of combined measles and rubella live attenuated vaccine].

Takeuchi Y, Togashi T, Sunakawa K, Katou T, Kamiya H, Nakayama T. Takeuchi Y, et al. Among authors: nakayama t. Kansenshogaku Zasshi. 2002 Jan;76(1):56-62. doi: 10.11150/kansenshogakuzasshi1970.76.56. Kansenshogaku Zasshi. 2002. PMID: 11852475 Clinical Trial. Japanese.

8

Current status of measles in Japan.

Nakayama T, Zhou J, Fujino M. Nakayama T, et al. J Infect Chemother. 2003 Mar;9(1):1-7. doi: 10.1007/s10156-002-0206-6. J Infect Chemother. 2003. PMID: 12673398 Review.

9

[Prevention of infectious diseases and vaccine benefit].

Nakayama T. Nakayama T. Nihon Rinsho. 2003 Mar;61 Suppl 3:381-5. Nihon Rinsho. 2003. PMID: 12718000 Review. Japanese. No abstract available.

10

H1 genotype of measles virus was detected in outbreaks in Japan after 2000.

Zhou J, Fujino M, Inou Y, Kumada A, Aoki Y, Iwata S, Nakayama T. Zhou J, et al. Among authors: nakayama t. J Med Virol. 2003 Aug;70(4):642-8. doi: 10.1002/jmv.10443. J Med Virol. 2003. PMID: 12794730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results